[Pubmed] Regarding the "Efgartigimod versus standard of care in new-onset AChR subtype generalized myasthenia gravis: A
Posté : 13 sept. 2025 12:00
Clin Immunol. 2025 Sep 11;281:110603. doi: 10.1016/j.clim.2025.110603. Online ahead of print.
NO ABSTRACT
PMID:40945804 | DOI:10.1016/j.clim.2025.110603
Source: https://pubmed.ncbi.nlm.nih.gov/4094580 ... t9+e462414